Symmetry Investments LP Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Symmetry Investments LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 26, 2022	SELL	$83.14 - $145.99 $831,400 - $1.46 Million	-10,000 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$110.08 - $142.92 $1.1 Million - $1.43 Million	10,000 New	10,000 $1.19 Million
Q4 2021 Feb 10, 2022	SELL	$99.73 - $148.48 $658,218 - $979,967	-6,600 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$98.85 - $138.91 $929,190 - $1.31 Million	-9,400 Reduced 58.75%	6,600 $917,000
Q2 2021 Jul 27, 2021	SELL	$65.78 - $105.02 $1.91 Million - $3.05 Million	-29,001 Reduced 64.45%	16,000 $1.55 Million
Q1 2021 May 10, 2021	BUY	$64.07 - $91.75 $2.88 Million - $4.13 Million	45,001 New	45,001 $3.08 Million

792K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $2.8B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Symmetry Investments LP, based on Form 13F filings with the SEC.

Stay updated on Symmetry Investments LP with notifications on news.